Novocure's Optune Lua device has received FDA approval for treating non-small cell lung cancer, claiming to disrupt malignant cell division through electric fields. The approval follows a controversial Phase 3 trial showing a 26% reduced risk of death when combined with standard therapies, although concerns about the trial's design and results have been raised. This approval could significantly boost Novocure's revenue, which has been lagging behind expenditures.
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.
